Dramatic Rise in Suicide Related Visits at Children’s Hospitals AND more on Best 5 Monday Reads

1) Dramatic Rise in Suicide-Related Visits at Children’s Hospitals

The percentage of children and adolescents presenting at US pediatric hospitals for suicidal ideation (SI) or suicidal attempts (SAs) doubled from 2008 to 2015, new research shows.

On reading this study, Dr. Cora Collette Breuner, MD, MPH, a prominent pediatrician, urged clinicians “not to be bummed out when you read this.”

Rather, “the take-home message of this study is that it gives you a road map what to do with this higher number of youngsters who are suicidal, rather than just throwing your hands in the air and thinking that these kids are doomed,” she emphasized.

She advised clinicians to “be aware of the trend, especially the seasonality —which may be connected not only to academics but also to changes in sleep patterns during fall and spring.”

Additionally, “as found in the study, kids as young as 5 years old can also have thoughts of self-harm,” she said.

2) Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

“Clinicians must take active steps to reduce the risk of T2D and raised triglycerides in patients with schizophrenia,” the authors concluded.

3) National trial: EEG brain tests help patients overcome depression

Imagine millions of depressed Americans getting their brain activity measured and undergoing blood tests to determine which antidepressant would work best. Imagine some of them receiving “brain training” or magnetic stimulation to make their brains more amenable to those treatments.

4) FDA Approves First Nonopioid Drug for Opioid Withdrawal

The committee found the drug to be both safe and effective in reducing symptoms such as diarrhea, nausea, vomiting, anxiety, and an overall feeling of sickness that often keeps patients from successfully withdrawing from opioids.

5) Antidepressant Use for Insomnia: Is It Effective?

Despite the widespread use of antidepressants for treating insomnia, the evidence for their effectiveness remains limited, according to a new review published in the Cochrane Library.

So what’s next?

High quality trials of antidepressants for insomnia are needed to provide better evidence to inform clinical practice. Additionally, health professionals and patients should be made aware of the current paucity of evidence for antidepressants commonly used for insomnia management.

Thank you and see you later!

Best Regards,

Vikram


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s